The Manila Times

Press Release: Sanofi’s Qfitlia and Cablivi approved in China, expanding care for rare diseases

Qfitlia (fitusiran) is a first-in-class AT-lowering therapy approved by the NMPA. Qfitlia prevents bleeds and helps rebalance hemostasis by lowering AT, a protein that inhibits blood clotting, to ...
The Manila Times

Zealand Pharma outlines Metabolic Frontier 2030 strategy to become a generational biotech leader in obesity and metabolic health

Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary ...

Dhurandhar Box Office collection Day 6: Ranveer Singh’s spy-thriller continues its strong streak, earns Rs 180 crore during first week

Ranveer Singh’s Dhurandhar continues its strong box office run, crossing an impressive Rs 150 crore in just five days. The film is now steadily heading toward the Rs 200 crore milestone.